Surgery Partners Stock Cash And Equivalents

SGRY Stock

USD 24.21 0.18 0.74%

Surgery Partners fundamentals help investors to digest information that contributes to Surgery Partners' financial success or failures. It also enables traders to predict the movement of Surgery Stock. The fundamental analysis module provides a way to measure Surgery Partners' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Surgery Partners stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Surgery Partners Company Cash And Equivalents Analysis

Surgery Partners' Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Cash

Bank Deposits

+

Liquidities

More About Cash And Equivalents | All Equity Analysis

Current Surgery Partners Cash And Equivalents

227.4 M

Most of Surgery Partners' fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Surgery Partners is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Surgery Cash And Equivalents Driver Correlations

Understanding the fundamental principles of building solid financial models for Surgery Partners is extremely important. It helps to project a fair market value of Surgery Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since Surgery Partners' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Surgery Partners' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Surgery Partners' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Property Plant Equipment	Net Tangible Assets	Current Deferred Revenue	Long Term Investments	Short Long Term Debt	Common Stock	Short Term Investments	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.83	0.56	-0.75	0.97	0.98	0.99	1.0	0.89	0.98	0.97	0.59	0.92	0.0	0.05	0.89	0.96	0.76	0.81	0.95	0.79	0.5	0.58	-0.69
Total Stockholder Equity	0.83		0.21	-0.81	0.88	0.73	0.84	0.81	0.64	0.83	0.77	0.36	0.9	0.15	0.3	0.91	0.81	0.9	0.65	0.74	0.98	0.63	0.79	-0.93
Net Debt	0.56	0.21		-0.11	0.4	0.6	0.51	0.56	0.71	0.52	0.65	0.49	0.34	-0.01	-0.37	0.29	0.36	0.13	0.46	0.56	0.07	-0.08	-0.08	-0.08
Retained Earnings	-0.75	-0.81	-0.11		-0.82	-0.72	-0.8	-0.71	-0.55	-0.79	-0.73	-0.34	-0.89	-0.26	-0.5	-0.79	-0.72	-0.81	-0.73	-0.67	-0.88	-0.58	-0.74	0.83
Accounts Payable	0.97	0.88	0.4	-0.82		0.92	0.98	0.95	0.76	0.96	0.92	0.48	0.92	0.06	0.2	0.96	0.96	0.89	0.76	0.89	0.86	0.63	0.71	-0.78
Long Term Debt	0.98	0.73	0.6	-0.72	0.92		0.97	0.98	0.91	0.97	0.96	0.66	0.89	-0.03	0.0	0.8	0.93	0.64	0.83	0.96	0.7	0.39	0.48	-0.59
Net Receivables	0.99	0.84	0.51	-0.8	0.98	0.97		0.98	0.85	0.99	0.95	0.58	0.92	0.05	0.1	0.9	0.95	0.8	0.79	0.92	0.8	0.53	0.63	-0.72
Good Will	1.0	0.81	0.56	-0.71	0.95	0.98	0.98		0.9	0.97	0.95	0.62	0.9	-0.05	-0.01	0.87	0.96	0.72	0.81	0.96	0.76	0.47	0.54	-0.65
Total Liab	0.89	0.64	0.71	-0.55	0.76	0.91	0.85	0.9		0.87	0.89	0.57	0.79	-0.02	-0.18	0.66	0.78	0.48	0.77	0.91	0.57	0.21	0.36	-0.49
Total Current Assets	0.98	0.83	0.52	-0.79	0.96	0.97	0.99	0.97	0.87		0.95	0.54	0.91	0.13	0.16	0.88	0.94	0.79	0.79	0.94	0.8	0.46	0.67	-0.73
Short Term Debt	0.97	0.77	0.65	-0.73	0.92	0.96	0.95	0.95	0.89	0.95		0.51	0.92	0.02	0.09	0.84	0.91	0.69	0.85	0.96	0.72	0.44	0.48	-0.63
Intangible Assets	0.59	0.36	0.49	-0.34	0.48	0.66	0.58	0.62	0.57	0.54	0.51		0.45	-0.24	-0.33	0.33	0.48	0.18	0.34	0.47	0.31	0.18	0.07	-0.19
Property Plant Equipment	0.92	0.9	0.34	-0.89	0.92	0.89	0.92	0.9	0.79	0.91	0.92	0.45		0.06	0.28	0.89	0.9	0.79	0.85	0.89	0.91	0.58	0.63	-0.8
Net Tangible Assets	0.0	0.15	-0.01	-0.26	0.06	-0.03	0.05	-0.05	-0.02	0.13	0.02	-0.24	0.06		0.48	-0.02	-0.09	0.27	-0.1	-0.02	0.18	-0.38	0.53	-0.48
Current Deferred Revenue	0.05	0.3	-0.37	-0.5	0.2	0.0	0.1	-0.01	-0.18	0.16	0.09	-0.33	0.28	0.48		0.26	0.14	0.43	0.13	0.06	0.43	0.28	0.58	-0.47
Long Term Investments	0.89	0.91	0.29	-0.79	0.96	0.8	0.9	0.87	0.66	0.88	0.84	0.33	0.89	-0.02	0.26		0.9	0.94	0.71	0.8	0.89	0.78	0.73	-0.79
Short Long Term Debt	0.96	0.81	0.36	-0.72	0.96	0.93	0.95	0.96	0.78	0.94	0.91	0.48	0.9	-0.09	0.14	0.9		0.77	0.79	0.94	0.79	0.58	0.6	-0.65
Common Stock	0.76	0.9	0.13	-0.81	0.89	0.64	0.8	0.72	0.48	0.79	0.69	0.18	0.79	0.27	0.43	0.94	0.77		0.54	0.63	0.9	0.7	0.89	-0.9
Short Term Investments	0.81	0.65	0.46	-0.73	0.76	0.83	0.79	0.81	0.77	0.79	0.85	0.34	0.85	-0.1	0.13	0.71	0.79	0.54		0.88	0.67	0.4	0.34	-0.53
Long Term Debt Total	0.95	0.74	0.56	-0.67	0.89	0.96	0.92	0.96	0.91	0.94	0.96	0.47	0.89	-0.02	0.06	0.8	0.94	0.63	0.88		0.71	0.36	0.48	-0.6
Capital Surpluse	0.79	0.98	0.07	-0.88	0.86	0.7	0.8	0.76	0.57	0.8	0.72	0.31	0.91	0.18	0.43	0.89	0.79	0.9	0.67	0.71		0.65	0.82	-0.94
Net Invested Capital	0.5	0.63	-0.08	-0.58	0.63	0.39	0.53	0.47	0.21	0.46	0.44	0.18	0.58	-0.38	0.28	0.78	0.58	0.7	0.4	0.36	0.65		0.45	-0.45
Net Working Capital	0.58	0.79	-0.08	-0.74	0.71	0.48	0.63	0.54	0.36	0.67	0.48	0.07	0.63	0.53	0.58	0.73	0.6	0.89	0.34	0.48	0.82	0.45		-0.89
Capital Stock	-0.69	-0.93	-0.08	0.83	-0.78	-0.59	-0.72	-0.65	-0.49	-0.73	-0.63	-0.19	-0.8	-0.48	-0.47	-0.79	-0.65	-0.9	-0.53	-0.6	-0.94	-0.45	-0.89

Click cells to compare fundamentals

Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

Competition

Predict Surgery Partners

Surgery Cash And Cash Equivalents Changes

Cash And Cash Equivalents Changes

(116.9 Million)

Surgery Partners reported Cash And Cash Equivalents Changes of (123.05 Million) in 2024

In accordance with the recently published financial statements, Surgery Partners has 227.4 M in Cash And Equivalents. This is 72.3% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The cash and equivalents for all United States stocks is 91.58% higher than that of the company.

Surgery Cash And Equivalents Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Surgery Partners' direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Surgery Partners could also be used in its relative valuation, which is a method of valuing Surgery Partners by comparing valuation metrics of similar companies.

Surgery Partners is currently under evaluation in cash and equivalents category among its peers.

Surgery Partners ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Surgery Partners' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Surgery Partners' managers, analysts, and investors.

Environmental

Governance

Social

Surgery Fundamentals

	Return On Equity	0.0036
	Return On Asset	0.0401
	Profit Margin	(0.05) %
	Operating Margin	0.20 %
	Current Valuation	6.53 B
	Shares Outstanding	127.61 M
	Shares Owned By Insiders	1.47 %
	Shares Owned By Institutions	98.53 %
	Number Of Shares Shorted	10.25 M
	Price To Earning	61.84 X
	Price To Book	1.73 X
	Price To Sales	0.99 X
	Revenue	3.11 B
	Gross Profit	745.6 M
	EBITDA	501.4 M
	Net Income	12.5 M
	Cash And Equivalents	227.4 M
	Cash Per Share	2.58 X
	Total Debt	393.5 M
	Debt To Equity	1.44 %
	Current Ratio	1.51 X
	Book Value Per Share	14.18 X
	Cash Flow From Operations	300.1 M
	Short Ratio	5.82 X
	Earnings Per Share	(1.33) X
	Price To Earnings To Growth	1.66 X
	Target Price	31.91
	Number Of Employees	15 K
	Beta	2.74
	Market Capitalization	3.09 B
	Total Asset	7.89 B
	Retained Earnings	(737.3 M)
	Working Capital	495 M
	Current Asset	310.96 M
	Current Liabilities	181.29 M
	Net Asset	7.89 B

About Surgery Partners Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Surgery Partners's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Surgery Partners using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Surgery Partners based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC